Capricor Therapeutics, Inc. Liquidation Value
CAPR
Other
Cash & Equivalents
$287.85M
As of 2025-12-31
Current Price: N/A
Key Metrics
Cash Liquidation Value
Cash minus Total Obligations
Cash: $287.85M
Total Obligations: -$50.36M
$237.49M
Per share: $4.14
Period: 2025-12-31
Liquid Liquidation Value
Cash + AR minus Total Obligations
Cash: $287.85M
AR: $0
Total Obligations: -$50.36M
$237.49M
Per share: $4.14
Period: 2025-12-31
Operating Liquidation Value
Cash + AR + Inventory minus Total Obligations
Cash: $287.85M
AR: $0
Inventory: $0
Total Obligations: -$50.36M
$237.49M
Per share: $4.14
Period: 2025-12-31
Build your own liquidation scenario
Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.
Liquidation Ladder
| Metric | Total | Per Share |
|---|---|---|
| Cash Liquidation Value | $237.49M | $4.14 |
| Liquid Liquidation Value | $237.49M | $4.14 |
| Operating Liquidation Value | $237.49M | $4.14 |
Key Components (as of 2025-12-31)
| Cash & Equivalents | $287.85M |
| Accounts Receivable | N/A |
| Inventory | N/A |
| Current Liabilities | $35.84M |
| Long-term Debt | N/A |
| Op. Lease Liability | $14.52M |
| Finance Lease | N/A |
| Shares Outstanding | 57.4M |
Explore all 144 XBRL tags and build your own scenario → Open Calculator
Historical
| Period | Cash | AR | Inventory | AP | Curr Liab | LT Debt | Op Lease | Fin Lease |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $287.85M | N/A | N/A | $1.65M | $35.84M | N/A | $14.52M | N/A |
| 2025-09-30 | $19.51M | N/A | N/A | $2.72M | $28.15M | N/A | $14.54M | N/A |
| 2025-06-30 | $23.24M | N/A | N/A | $4.81M | $28.40M | N/A | $1.04M | N/A |
| 2025-03-31 | $28.79M | N/A | N/A | $5.25M | $22.34M | N/A | $1.25M | N/A |
| 2024-12-31 | $11.29M | N/A | N/A | $3.28M | $21.03M | N/A | $1.45M | N/A |
| 2024-09-30 | $68.38M | N/A | N/A | N/A | $20.48M | N/A | $1.65M | N/A |
| 2024-06-30 | $10.69M | N/A | N/A | N/A | $22.35M | N/A | $1.84M | N/A |
| 2024-03-31 | $6.21M | N/A | N/A | N/A | $26.38M | N/A | $2.02M | N/A |
▼ Community Notes